Your browser doesn't support javascript.
loading
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation.
De Pastena, Matteo; van Bodegraven, Eduard A; Mungroop, Timothy H; Vissers, Frederique L; Jones, Leia R; Marchegiani, Giovanni; Balduzzi, Alberto; Klompmaker, Sjors; Paiella, Salvatore; Tavakoli Rad, Shazad; Groot Koerkamp, Bas; van Eijck, Casper; Busch, Olivier R; de Hingh, Ignace; Luyer, Misha; Barnhill, Caleb; Seykora, Thomas; Maxwell T, Trudeau; de Rooij, Thijs; Tuveri, Massimiliano; Malleo, Giuseppe; Esposito, Alessandro; Landoni, Luca; Casetti, Luca; Alseidi, Adnan; Salvia, Roberto; Steyerberg, Ewout W; Abu Hilal, Mohammad; Vollmer, Charles M; Besselink, Marc G; Bassi, Claudio.
Afiliação
  • De Pastena M; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • van Bodegraven EA; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Mungroop TH; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Vissers FL; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Jones LR; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Marchegiani G; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Balduzzi A; Department of Surgery, Poliambulanza Institute Hospital Foundation, Brescia, Italy.
  • Klompmaker S; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Paiella S; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Tavakoli Rad S; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Groot Koerkamp B; Department of Radiology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • van Eijck C; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Busch OR; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • de Hingh I; Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Luyer M; Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Barnhill C; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Seykora T; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
  • Maxwell T T; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
  • de Rooij T; Department of Surgery, Virginia Mason Medical Center, Seattle, WA.
  • Tuveri M; Department of Surgery, University of Pennsylvania, Philadelphia, PA.
  • Malleo G; Department of Surgery, University of Pennsylvania, Philadelphia, PA.
  • Esposito A; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Landoni L; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Casetti L; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Alseidi A; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Salvia R; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Steyerberg EW; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Abu Hilal M; Department of Surgery, Virginia Mason Medical Center, Seattle, WA.
  • Vollmer CM; Department of Surgery, University of California, San Francisco, CA.
  • Besselink MG; General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Bassi C; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
Ann Surg ; 277(5): e1099-e1105, 2023 05 01.
Article em En | MEDLINE | ID: mdl-35797608
ABSTRACT

OBJECTIVE:

To develop 2 distinct preoperative and intraoperative risk scores to predict postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP) to improve preventive and mitigation strategies, respectively.

BACKGROUND:

POPF remains the most common complication after DP. Despite several known risk factors, an adequate risk model has not been developed yet.

METHODS:

Two prediction risk scores were designed using data of patients undergoing DP in 2 Italian centers (2014-2016) utilizing multivariable logistic regression. The preoperative score (calculated before surgery) aims to facilitate preventive strategies and the intraoperative score (calculated at the end of surgery) aims to facilitate mitigation strategies. Internal validation was achieved using bootstrapping. These data were pooled with data from 5 centers from the United States and the Netherlands (2007-2016) to assess discrimination and calibration in an internal-external validation procedure.

RESULTS:

Overall, 1336 patients after DP were included, of whom 291 (22%) developed POPF. The preoperative distal fistula risk score (preoperative D-FRS) included 2 variables pancreatic neck thickness [odds ratio 1.14; 95% confidence interval (CI) 1.11-1.17 per mm increase] and pancreatic duct diameter (OR 1.46; 95% CI 1.32-1.65 per mm increase). The model performed well with an area under the receiver operating characteristic curve of 0.83 (95% CI 0.78-0.88) and 0.73 (95% CI 0.70-0.76) upon internal-external validation. Three risk groups were identified low risk (<10%), intermediate risk (10%-25%), and high risk (>25%) for POPF with 238 (18%), 684 (51%), and 414 (31%) patients, respectively. The intraoperative risk score (intraoperative D-FRS) added body mass index, pancreatic texture, and operative time as variables with an area under the receiver operating characteristic curve of 0.80 (95% CI 0.74-0.85).

CONCLUSIONS:

The preoperative and the intraoperative D-FRS are the first validated risk scores for POPF after DP and are readily available at http//www.pancreascalculator.com . The 3 distinct risk groups allow for personalized treatment and benchmarking.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatectomia / Pancreaticoduodenectomia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancreatectomia / Pancreaticoduodenectomia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article